Literature DB >> 25950109

Effects of a Presidential Candidate's Comments on HPV Vaccine.

Rachel A Zucker1, Paul L Reiter, Melissa K Mayer, Noel T Brewer.   

Abstract

During and after the 2011 Republican presidential debate, a candidate questioned the safety of HPV vaccine. The authors aimed to determine the effect of these comments on parents. A national sample of 327 parents with adolescent sons ages 11-17 years completed online surveys in fall 2010 (baseline, about 1 year before the debate) and 2011 (follow-up, about 1 month after the debate). The authors used regression models to examine the association of parents' awareness of the candidate's comments with HPV vaccine initiation among their sons, their willingness to get sons free HPV vaccine, and their beliefs about potential harms of HPV vaccine. Overall, 17% of parents reported hearing about the Republican presidential candidate's comments about HPV vaccine. Parents aware of the comments had a larger increase between baseline and follow-up in the belief that HPV vaccine might cause short-term health problems compared with parents who were not aware. Although the candidate's comments may have increased some parents' beliefs about the short-term harms of HPV vaccine, the comments had no effect on other beliefs, willingness to vaccinate, or behavior. Having accurate information about HPV vaccine that is readily available to the public during such controversies may diminish their effect.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25950109      PMCID: PMC4697928          DOI: 10.1080/10810730.2015.1018577

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  22 in total

1.  Sorting through search results: a content analysis of HPV vaccine information online.

Authors:  Kelly Madden; Xiaoli Nan; Rowena Briones; Leah Waks
Journal:  Vaccine       Date:  2011-10-19       Impact factor: 3.641

2.  National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-31       Impact factor: 17.586

3.  Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

Authors:  Julianne Gee; Allison Naleway; Irene Shui; James Baggs; Ruihua Yin; Rong Li; Martin Kulldorff; Edwin Lewis; Bruce Fireman; Matthew F Daley; Nicola P Klein; Eric S Weintraub
Journal:  Vaccine       Date:  2011-09-09       Impact factor: 3.641

4.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

5.  The HPV vaccine: a content analysis of online news stories.

Authors:  Melissa A Habel; Nicole Liddon; Jo E Stryker
Journal:  J Womens Health (Larchmt)       Date:  2009-03       Impact factor: 2.681

6.  Trends in HPV vaccine initiation among adolescent females in North Carolina, 2008-2010.

Authors:  Jennifer L Moss; Melissa B Gilkey; Paul L Reiter; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-20       Impact factor: 4.254

7.  Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males.

Authors:  Paul L Reiter; Annie-Laurie McRee; Jessica K Pepper; Melissa B Gilkey; Kayoll V Galbraith; Noel T Brewer
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

Review 8.  Predictors of HPV vaccine acceptability: a theory-informed, systematic review.

Authors:  Noel T Brewer; Karah I Fazekas
Journal:  Prev Med       Date:  2007-06-02       Impact factor: 4.018

9.  Disparities in how parents are learning about the human papillomavirus vaccine.

Authors:  Jessica Hughes; Joan R Cates; Nicole Liddon; Jennifer S Smith; Sami L Gottlieb; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

10.  National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-08-30       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.